Clinical Trial 55841

Chattanooga, TN 37421


Summary:

Be Proactive About Your Liver Cirrhosis

Nearly half of people living with cirrhosis get hepatic encephalopathy (HE). HE is complication of advanced liver cirrhosis that can cause severe episodes of mental and physical decline. Clinsearch is looking to see if a study medicine, rifaximin, can safely prevent HE in adults with advanced liver cirrhosis.


To qualify, to must:

  • Be between the ages of 18 and 70
  • Have a diagnosis of advanced liver cirrhosis
  • Have not been diagnosed with overt HE (a severe form of HE)
  • Do not experience any cognitive issues due to HE or any other illness
  • Do not have an active COVID-19 infection


Qualified Participants May Receive:

Qualified participants will receive:

  • Study-related medication at no cost
  • Study-related medical exams at no cost


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.